Latest News and Press Releases

NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Aptatek Biosciences (www.aptatek.com) which is developing a digital at-home health-maintenance system...

NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Ancilia, Inc., which is developing therapies to specifically target the viral components of the gut...

PHILADELPHIA, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Aptatek Biosciences (www.aptatek.com) which is developing a digital at-home health-maintenance...

NEW YORK, June 21, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Applied Glycan Technologies, Inc. (http://www.appliedglycan.com), which is developing a topical...

PHILADELPHIA, April 17, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that BrachyThermix, which has developed a medical device to improve outcomes of cancer surgery...

NEW YORK, April 05, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Handii 3D, which is developing hand and upper extremity splints for cerebral palsy patients, was...

NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that its previously announced, second closed-end investment pool (Pool II) solely funded by current, active...

NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announced today that it has formed a “sidecar” fund (https://sidecarfund.bioangels.net/) allowing accredited investors who...

NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Avisi Technologies, LLC, which develops an eye implant for glaucoma treatment, was named “Best of the...

NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in Houston-based Salarius Pharmaceuticals, which is developing epigenetic...